CITIGROUP INC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$29,540,000
+2004.0%
857,481
+920.5%
0.02%
+1800.0%
Q2 2020$1,404,000
+85.2%
84,029
+59.7%
0.00%0.0%
Q1 2020$758,000
-63.4%
52,604
-15.0%
0.00%0.0%
Q4 2019$2,071,000
+10.7%
61,888
-30.7%
0.00%0.0%
Q3 2019$1,871,000
+261.9%
89,368
+260.0%
0.00%
Q2 2019$517,000
+140.5%
24,823
+157.8%
0.00%
Q1 2019$215,000
-87.2%
9,630
-86.3%
0.00%
-100.0%
Q4 2018$1,680,000
+226.2%
70,246
+272.4%
0.00%
Q3 2018$515,000
+2.2%
18,864
+0.6%
0.00%
Q2 2018$504,000
-35.1%
18,752
-23.1%
0.00%
-100.0%
Q1 2018$776,000
-50.3%
24,373
-41.0%
0.00%0.0%
Q4 2017$1,562,000
+134.2%
41,287
+53.6%
0.00%0.0%
Q3 2017$667,000
+41.6%
26,880
+17.4%
0.00%
Q2 2017$471,000
+60.2%
22,894
+68.8%
0.00%
Q1 2017$294,000
-70.8%
13,564
-72.5%
0.00%
-100.0%
Q4 2016$1,008,000
+2300.0%
49,307
+1663.5%
0.00%
Q3 2016$42,000
+27.3%
2,796
-9.7%
0.00%
Q2 2016$33,000
-73.4%
3,096
-66.4%
0.00%
Q1 2016$124,000
+39.3%
9,203
+90.8%
0.00%
Q4 2015$89,000
+888.9%
4,823
+1251.0%
0.00%
Q3 2015$9,0003570.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders